Cargando…

Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40

INTRODUCTION: Nomograms are proven in “individualized risk prediction” in sarcomas and breast and prostate cancers. Incorporating immunohistochemical markers and histopathological parameters can enhance accuracy of these graphical representations of statistical predictive models concerning metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Ankita, Natarajan, Srikant, Manaktala, Nidhi, Boaz, Karen, KP, Nandita, Lewis, Amitha, Yellapurkar, Shweta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478775/
https://www.ncbi.nlm.nih.gov/pubmed/37674659
http://dx.doi.org/10.2147/CMAR.S408772
_version_ 1785101421938475008
author Sharma, Ankita
Natarajan, Srikant
Manaktala, Nidhi
Boaz, Karen
KP, Nandita
Lewis, Amitha
Yellapurkar, Shweta
author_facet Sharma, Ankita
Natarajan, Srikant
Manaktala, Nidhi
Boaz, Karen
KP, Nandita
Lewis, Amitha
Yellapurkar, Shweta
author_sort Sharma, Ankita
collection PubMed
description INTRODUCTION: Nomograms are proven in “individualized risk prediction” in sarcomas and breast and prostate cancers. Incorporating immunohistochemical markers and histopathological parameters can enhance accuracy of these graphical representations of statistical predictive models concerning metastasis. D2-40, a monoclonal antibody to podoplanin (regulator of motility expressed in malignant epithelial cells), dually predicts metastatic potential of tumour by estimating the motile tumour phenotype and by detecting lymphatic vessels/density, both essential to metastasis in OSCC. Thus, we propose a model that incorporates D2-40 immunostaining of individual tumour cells (ITC) too with other variables (seen in H+E staining) as a predictive nomogram. METHODS: Sixty cases of OSCC were selected with equal number of cases (n=30) of pN0 and pN+ status. Bryne’s grading of invasive front of tumour (ITF) was done on H+E-stained slides followed by D2-40 immunostaining for ITCs at ITF and lymphatic vessels. Multivariate regression analysis was used to generate the nomogram of LNM where the predictive contribution of each covariate, namely depth of invasion, D2-40-stained ITCs, gender, histological grade, and worst pattern of invasion (WPOI), was plotted on a scale of 1–100 points. RESULTS: The nomogram showed that the strongest variable in OSCC was the WPOI in H+E-stained section followed by D2-40-positive ITCs and gender. DISCUSSION: Our predictive nomogram for LNM in OSCC surprisingly showed that a tumour with lower score of WPOI (islands vs ITC) showed numerous D2-40-positive ITCs, drastically increasing the probability of metastasis. The concept of “individualized risk prediction” can be used to predict lymph node metastasis using a variety of histopathological criteria that can be visualized in routine and immunohistochemical staining in OSCC with the aid of a nomogram.
format Online
Article
Text
id pubmed-10478775
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104787752023-09-06 Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40 Sharma, Ankita Natarajan, Srikant Manaktala, Nidhi Boaz, Karen KP, Nandita Lewis, Amitha Yellapurkar, Shweta Cancer Manag Res Original Research INTRODUCTION: Nomograms are proven in “individualized risk prediction” in sarcomas and breast and prostate cancers. Incorporating immunohistochemical markers and histopathological parameters can enhance accuracy of these graphical representations of statistical predictive models concerning metastasis. D2-40, a monoclonal antibody to podoplanin (regulator of motility expressed in malignant epithelial cells), dually predicts metastatic potential of tumour by estimating the motile tumour phenotype and by detecting lymphatic vessels/density, both essential to metastasis in OSCC. Thus, we propose a model that incorporates D2-40 immunostaining of individual tumour cells (ITC) too with other variables (seen in H+E staining) as a predictive nomogram. METHODS: Sixty cases of OSCC were selected with equal number of cases (n=30) of pN0 and pN+ status. Bryne’s grading of invasive front of tumour (ITF) was done on H+E-stained slides followed by D2-40 immunostaining for ITCs at ITF and lymphatic vessels. Multivariate regression analysis was used to generate the nomogram of LNM where the predictive contribution of each covariate, namely depth of invasion, D2-40-stained ITCs, gender, histological grade, and worst pattern of invasion (WPOI), was plotted on a scale of 1–100 points. RESULTS: The nomogram showed that the strongest variable in OSCC was the WPOI in H+E-stained section followed by D2-40-positive ITCs and gender. DISCUSSION: Our predictive nomogram for LNM in OSCC surprisingly showed that a tumour with lower score of WPOI (islands vs ITC) showed numerous D2-40-positive ITCs, drastically increasing the probability of metastasis. The concept of “individualized risk prediction” can be used to predict lymph node metastasis using a variety of histopathological criteria that can be visualized in routine and immunohistochemical staining in OSCC with the aid of a nomogram. Dove 2023-09-01 /pmc/articles/PMC10478775/ /pubmed/37674659 http://dx.doi.org/10.2147/CMAR.S408772 Text en © 2023 Sharma et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sharma, Ankita
Natarajan, Srikant
Manaktala, Nidhi
Boaz, Karen
KP, Nandita
Lewis, Amitha
Yellapurkar, Shweta
Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40
title Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40
title_full Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40
title_fullStr Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40
title_full_unstemmed Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40
title_short Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40
title_sort prognostic nomogram for lymph-node metastasis in oral squamous cell carcinoma (oscc) using immunohistochemical marker d2-40
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478775/
https://www.ncbi.nlm.nih.gov/pubmed/37674659
http://dx.doi.org/10.2147/CMAR.S408772
work_keys_str_mv AT sharmaankita prognosticnomogramforlymphnodemetastasisinoralsquamouscellcarcinomaosccusingimmunohistochemicalmarkerd240
AT natarajansrikant prognosticnomogramforlymphnodemetastasisinoralsquamouscellcarcinomaosccusingimmunohistochemicalmarkerd240
AT manaktalanidhi prognosticnomogramforlymphnodemetastasisinoralsquamouscellcarcinomaosccusingimmunohistochemicalmarkerd240
AT boazkaren prognosticnomogramforlymphnodemetastasisinoralsquamouscellcarcinomaosccusingimmunohistochemicalmarkerd240
AT kpnandita prognosticnomogramforlymphnodemetastasisinoralsquamouscellcarcinomaosccusingimmunohistochemicalmarkerd240
AT lewisamitha prognosticnomogramforlymphnodemetastasisinoralsquamouscellcarcinomaosccusingimmunohistochemicalmarkerd240
AT yellapurkarshweta prognosticnomogramforlymphnodemetastasisinoralsquamouscellcarcinomaosccusingimmunohistochemicalmarkerd240